Public health aspects of obstructive sleep apnoea

Thorax

Volumn 53, Issue 5, 1998, Pages 408-409

  Gibson, G J ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SLEEP APNEA SYNDROME; TREATMENT PLANNING; UVULOPALATOPHARYNGOPLASTY;

EID: 0031812283     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.53.5.408     Document Type: Review

References (9)

1. Wright J, Sheldon T. Sleep apnoea and its impact on public health. Thorax 1998;53:410-3.
2. Davies RJO. Cardiovascular aspects of obstructive sleep apnoea and the effect of nasal CPAP. Thorax 1998;53:416-8.
3. Douglas NJ. Systematic review of the efficacy of nasal CPAP. Thorax 1998;53:414-5.
4. Wright J, Johns R, Watt I, et al. Health effects of obstructive sleep apnoea and effectiveness of continuous positive airway pressure: a systematic review of the research evidence. BMJ 1997;314:851-60.
5. Australian Health Technology Advisory Committee. The effectiveness and cost effectiveness of nasal continuous positive airway pressure in the treatment of obstructive sleep apnoea in adults. Government Public Services, Canberra, 1996.
6. Young T, Peppard P, Palta M, et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 1997;157:1746-52.
7. Engleman HM, Martin SE, Kingshott RN, et al. Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax 1998;53:341-5.
8. Royal College of Physicians. Overweight and obese patients. London: Royal College of Physicians, 1997.
9. NHS Centre for Reviews and Dissemination. The prevention and treatment of obesity. Effective Health Care 1997;3: 1-11.